A BILL 
To amend the Controlled Substances Act with respect to 
the scheduling of fentanyl-related substances, and for 
other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Halt All Lethal Traf-
4
ficking of Fentanyl Act’’ or the ‘‘HALT Fentanyl Act’’. 
5
08:15 Dec 15, 2021
H6184
2 
•HR 6184 IH
SEC. 2. CLASS SCHEDULING OF FENTANYL-RELATED SUB-
1
STANCES. 
2
Section 202(c) of the Controlled Substances Act (21 
3
U.S.C. 812(c)) is amended by adding at the end of sched-
4
ule I the following: 
5
‘‘(e)(1) Unless specifically exempted or unless listed 
6
in another schedule, any material, compound, mixture, or 
7
preparation which contains any quantity of a fentanyl-re-
8
lated substance, or which contains the salts, isomers, and 
9
salts of isomers of a fentanyl-related substance whenever 
10
the existence of such salts, isomers, and salts of isomers 
11
is possible within the specific chemical designation. 
12
‘‘(2) For purposes of paragraph (1), except as pro-
13
vided in paragraph (3), the term ‘fentanyl-related sub-
14
stance’ means any substance that is structurally related 
15
to fentanyl by 1 or more of the following modifications: 
16
‘‘(A) By replacement of the phenyl portion of 
17
the phenethyl group by any monocycle, whether or 
18
not further substituted in or on the monocycle. 
19
‘‘(B) By substitution in or on the phenethyl 
20
group with alkyl, alkenyl, alkoxyl, hydroxyl, halo, 
21
haloalkyl, amino, or nitro groups. 
22
‘‘(C) By substitution in or on the piperidine 
23
ring with alkyl, alkenyl, alkoxyl, ester, ether, 
24
hydroxyl, halo, haloalkyl, amino, or nitro groups. 
25
08:15 Dec 15, 2021
H6184
3 
•HR 6184 IH
‘‘(D) By replacement of the aniline ring with 
1
any aromatic monocycle whether or not further sub-
2
stituted in or on the aromatic monocycle. 
3
‘‘(E) By replacement of the N–propionyl group 
4
with another acyl group. 
5
‘‘(3) A substance that satisfies the definition of the 
6
term ‘fentanyl-related substance’ in paragraph (2) shall 
7
nonetheless not be treated as a fentanyl-related substance 
8
subject to this schedule if the substance— 
9
‘‘(A) is controlled by action of the Attorney 
10
General under section 201; or 
11
‘‘(B) is otherwise expressly listed in a schedule 
12
other than this schedule. 
13
‘‘(4)(A) The Attorney General may by order publish 
14
in the Federal Register a list of substances that satisfy 
15
the definition of the term ‘fentanyl-related substance’ in 
16
paragraph (2). 
17
‘‘(B) The absence of a substance from a list published 
18
under subparagraph (A) does not negate the control status 
19
of the substance under this schedule if the substance satis-
20
fies the definition of the term ‘fentanyl-related substance’ 
21
in paragraph (2).’’. 
22
08:15 Dec 15, 2021
H6184
4 
•HR 6184 IH
SEC. 3. REGISTRATION REQUIREMENTS RELATED TO RE-
1
SEARCH. 
2
(a) ALTERNATIVE
REGISTRATION
PROCESS
FOR 
3
SCHEDULE I RESEARCH.—Section 303 of the Controlled 
4
Substances Act (21 U.S.C. 823) is amended by adding at 
5
the end the following: 
6
‘‘(l) SPECIAL PROVISIONS FOR PRACTITIONERS CON-
7
DUCTING CERTAIN RESEARCH WITH SCHEDULE I CON-
8
TROLLED SUBSTANCES.— 
9
‘‘(1) IN GENERAL.—Notwithstanding subsection 
10
(f), a practitioner may conduct research described in 
11
paragraph (2) of this subsection with 1 or more 
12
schedule I substances in accordance with subpara-
13
graph (A) or (B) of paragraph (3) of this sub-
14
section. 
15
‘‘(2) RESEARCH SUBJECT TO EXPEDITED PRO-
16
CEDURES.—Research described in this paragraph is 
17
research that— 
18
‘‘(A) is with respect to a drug that is the 
19
subject of an investigational use exemption 
20
under section 505(i) of the Federal Food, Drug, 
21
and Cosmetic Act; or 
22
‘‘(B) is— 
23
‘‘(i) conducted by the Department of 
24
Health and Human Services or the De-
25
partment of Veterans Affairs; or 
26
08:15 Dec 15, 2021
H6184
5 
•HR 6184 IH
‘‘(ii) funded partly or entirely by a 
1
grant, contract, cooperative agreement, or 
2
other transaction from the Department of 
3
Health and Human Services or the De-
4
partment of Veterans Affairs. 
5
‘‘(3) EXPEDITED PROCEDURES.— 
6
‘‘(A) RESEARCHER
WITH
A
CURRENT 
7
SCHEDULE I OR II RESEARCH REGISTRATION.— 
8
‘‘(i) IN GENERAL.—If a practitioner is 
9
registered to conduct research with a con-
10
trolled substance in schedule I or II, the 
11
practitioner may conduct research under 
12
this subsection on and after the date that 
13
is 30 days after the date on which the 
14
practitioner sends a notice to the Attorney 
15
General containing the following informa-
16
tion, with respect to each substance with 
17
which the practitioner will conduct the re-
18
search: 
19
‘‘(I) The chemical name of the 
20
substance. 
21
‘‘(II) The quantity of the sub-
22
stance to be used in the research. 
23
‘‘(III) Demonstration that the re-
24
search is in the category described in 
25
08:15 Dec 15, 2021
H6184
6 
•HR 6184 IH
paragraph (2), which demonstration 
1
may be satisfied— 
2
‘‘(aa) in the case of a grant, 
3
contract, cooperative agreement, 
4
or other transaction, or intra-
5
mural research project, by identi-
6
fying the sponsoring agency and 
7
supplying the number of the 
8
grant, 
contract, 
cooperative 
9
agreement, other transaction, or 
10
project; or 
11
‘‘(bb) in the case of an ap-
12
plication under section 505(i) of 
13
the Federal Food, Drug, and 
14
Cosmetic Act, by supplying the 
15
application number and the spon-
16
sor of record on the application. 
17
‘‘(IV) Demonstration that the re-
18
searcher is authorized to conduct re-
19
search with respect to the substance 
20
under the laws of the State in which 
21
the research will take place. 
22
‘‘(ii) VERIFICATION OF INFORMATION 
23
BY HHS OR VA.—Upon request from the 
24
Attorney General, the Secretary of Health 
25
08:15 Dec 15, 2021
H6184
7 
•HR 6184 IH
and Human Services or the Secretary of 
1
Veterans Affairs, as appropriate, shall 
2
verify information submitted by an appli-
3
cant under clause (i)(III). 
4
‘‘(B) RESEARCHER WITHOUT A CURRENT 
5
SCHEDULE I OR II RESEARCH REGISTRATION.— 
6
‘‘(i) IN GENERAL.—If a practitioner is 
7
not registered to conduct research with a 
8
controlled substance in schedule I or II, 
9
the practitioner may send a notice to the 
10
Attorney General containing the informa-
11
tion listed in subparagraph (A)(i), with re-
12
spect to each substance with which the 
13
practitioner will conduct the research. 
14
‘‘(ii) ATTORNEY GENERAL ACTION.— 
15
The Attorney General shall— 
16
‘‘(I) treat notice received under 
17
clause (i) as a sufficient application 
18
for a research registration; and 
19
‘‘(II) not later than 45 days of 
20
receiving such a notice that contains 
21
all information required under sub-
22
paragraph (A)(i)— 
23
‘‘(aa) register the applicant; 
24
or 
25
08:15 Dec 15, 2021
H6184
8 
•HR 6184 IH
‘‘(bb) serve an order to show 
1
cause upon the applicant in ac-
2
cordance with section 304(c). 
3
‘‘(4) ELECTRONIC SUBMISSIONS.—The Attorney 
4
General shall provide a means to permit a practi-
5
tioner to submit a notification under paragraph (3) 
6
electronically. 
7
‘‘(5) LIMITATION ON AMOUNTS.—A practitioner 
8
conducting research with a schedule I substance 
9
under this subsection may only possess the amounts 
10
of schedule I substance identified in— 
11
‘‘(A) the notification to the Attorney Gen-
12
eral under paragraph (3); or 
13
‘‘(B) a supplemental notification that the 
14
practitioner may send if the practitioner needs 
15
additional amounts for the research, which sup-
16
plemental notification shall include— 
17
‘‘(i) the name of the practitioner; 
18
‘‘(ii) the additional quantity needed of 
19
the substance; and 
20
‘‘(iii) an attestation that the research 
21
to be conducted with the substance is con-
22
sistent with the scope of the research that 
23
was the subject of the notification under 
24
paragraph (3). 
25
08:15 Dec 15, 2021
H6184
9 
•HR 6184 IH
‘‘(6) IMPORTATION
AND
EXPORTATION
RE-
1
QUIREMENTS NOT AFFECTED.—Nothing in this sub-
2
section alters the requirements of part A of title III, 
3
regarding the importation and exportation of con-
4
trolled substances.’’. 
5
(b) SEPARATE REGISTRATIONS NOT REQUIRED FOR 
6
ADDITIONAL RESEARCHER IN SAME INSTITUTION.—Sec-
7
tion 302(c) of the Controlled Substances Act (21 U.S.C. 
8
822(c)) is amended by adding at the end the following: 
9
‘‘(4) An agent or employee of a research insti-
10
tution that is conducting research with a controlled 
11
substance if— 
12
‘‘(A) the agent or employee is acting with-
13
in the scope of the professional practice of the 
14
agent or employee; 
15
‘‘(B) another agent or employee of the in-
16
stitution is registered to conduct research with 
17
a controlled substance in the same schedule; 
18
‘‘(C) the researcher who is so registered— 
19
‘‘(i) informs the Attorney General of 
20
the name, position title, and employing in-
21
stitution of the agent or employee who is 
22
not separately registered; 
23
08:15 Dec 15, 2021
H6184
10 
•HR 6184 IH
‘‘(ii) authorizes that agent or em-
1
ployee to perform research under the reg-
2
istration of the registered researcher; and 
3
‘‘(iii) affirms that any act taken by 
4
that agent or employee involving a con-
5
trolled substance shall be attributable to 
6
the registered researcher, as if the re-
7
searcher had directly committed the act, 
8
for purposes of any proceeding under sec-
9
tion 304(a) to suspend or revoke the reg-
10
istration of the registered researcher; and 
11
‘‘(D) the Attorney General does not, within 
12
30 days of receiving the information, authoriza-
13
tion, and affirmation described in subparagraph 
14
(C), refuse, for a reason listed in section 
15
304(a), to allow the agent or employee to pos-
16
sess the substance without a separate registra-
17
tion.’’. 
18
(c) SINGLE REGISTRATION FOR RELATED RESEARCH 
19
SITES.—Section 302(e) of the Controlled Substances Act 
20
(21 U.S.C. 822(e)) is amended by adding at the end the 
21
following: 
22
‘‘(3)(A) Notwithstanding paragraph (1), a person 
23
registered to conduct research with a controlled substance 
24
08:15 Dec 15, 2021
H6184
11 
•HR 6184 IH
under section 303(f) may conduct the research under a 
1
single registration if— 
2
‘‘(i) the research occurs exclusively on sites all 
3
of which are— 
4
‘‘(I) within the same city or county; and 
5
‘‘(II) under the control of the same institu-
6
tion, organization, or agency; and 
7
‘‘(ii) before commencing the research, the re-
8
searcher notifies the Attorney General of each site 
9
where— 
10
‘‘(I) the research will be conducted; or 
11
‘‘(II) the controlled substance will be 
12
stored or administered. 
13
‘‘(B) A site described in subparagraph (A) shall be 
14
included in a registration described in that subparagraph 
15
only if the researcher has notified the Attorney General 
16
of the site— 
17
‘‘(i) in the application for the registration; or 
18
‘‘(ii) before the research is conducted, or before 
19
the controlled substance is stored or administered, at 
20
the site. 
21
‘‘(C) The Attorney General may, in consultation with 
22
the Secretary, issue regulations addressing, with respect 
23
to research sites described in subparagraph (A)— 
24
08:15 Dec 15, 2021
H6184
12 
•HR 6184 IH
‘‘(i) the manner in which controlled substances 
1
may be delivered to the research sites; 
2
‘‘(ii) the storage and security of controlled sub-
3
stances at the research sites; 
4
‘‘(iii) the maintenance of records for the re-
5
search sites; and 
6
‘‘(iv) any other matters necessary to ensure ef-
7
fective controls against diversion at the research 
8
sites.’’. 
9
(d) NEW INSPECTION NOT REQUIRED IN CERTAIN 
10
SITUATIONS.—Section 302(f) of the Controlled Sub-
11
stances Act (21 U.S.C. 822(f)) is amended— 
12
(1) by striking ‘‘(f) The’’ and inserting ‘‘(f)(1) 
13
The’’; and 
14
(2) by adding at the end the following: 
15
‘‘(2)(A) If a person is registered to conduct research 
16
with a controlled substance and applies for a registration, 
17
or for a modification of a registration, to conduct research 
18
with a second controlled substance that is in the same 
19
schedule as the first controlled substance, or is in a sched-
20
ule with a higher numerical designation than the schedule 
21
of the first controlled substance, a new inspection by the 
22
Attorney General of the registered location is not required. 
23
‘‘(B) Nothing in subparagraph (A) shall prohibit the 
24
Attorney General from conducting an inspection that the 
25
08:15 Dec 15, 2021
H6184
13 
•HR 6184 IH
Attorney General determines necessary to ensure that a 
1
registrant maintains effective controls against diversion.’’. 
2
(e) CONTINUATION OF RESEARCH ON SUBSTANCES 
3
NEWLY ADDED TO SCHEDULE I.—Section 302 of the 
4
Controlled Substances Act (21 U.S.C. 822) is amended 
5
by adding at the end the following: 
6
‘‘(h) CONTINUATION OF RESEARCH ON SUBSTANCES 
7
NEWLY ADDED TO SCHEDULE I.—If a person is con-
8
ducting research on a substance when the substance is 
9
added to schedule I, and the person is already registered 
10
to conduct research with a controlled substance in sched-
11
ule I— 
12
‘‘(1) not later than 90 days after the scheduling 
13
of the newly scheduled substance, the person shall 
14
submit a completed application for registration or 
15
modification of existing registration, to conduct re-
16
search on the substance, in accordance with regula-
17
tions issued by the Attorney General for purposes of 
18
this paragraph; 
19
‘‘(2) the person may, notwithstanding sub-
20
sections (a) and (b), continue to conduct the re-
21
search on the substance until— 
22
‘‘(A) the person withdraws the application 
23
described in paragraph (1) of this subsection; 
24
or 
25
08:15 Dec 15, 2021
H6184
14 
•HR 6184 IH
‘‘(B) the Attorney General serves on the 
1
person an order to show cause proposing the 
2
denial of the application under section 304(c); 
3
‘‘(3) if the Attorney General serves an order to 
4
show cause as described in paragraph (2)(B) and 
5
the person requests a hearing, the hearing shall be 
6
held on an expedited basis and not later than 45 
7
days after the request is made, except that the hear-
8
ing may be held at a later time if so requested by 
9
the person; and 
10
‘‘(4) if the person sends a copy of the applica-
11
tion described in paragraph (1) to a manufacturer or 
12
distributor of the substance, receipt of the copy by 
13
the manufacturer or distributor shall constitute suf-
14
ficient evidence that the person is authorized to re-
15
ceive the substance.’’. 
16
(f) TREATMENT OF CERTAIN MANUFACTURING AC-
17
TIVITIES AS COINCIDENT TO RESEARCH.—Section 302 of 
18
the Controlled Substances Act (21 U.S.C. 822), as amend-
19
ed by subsection (e), is amended by adding at the end 
20
the following: 
21
‘‘(i) TREATMENT OF CERTAIN MANUFACTURING AC-
22
TIVITIES AS COINCIDENT TO RESEARCH.— 
23
‘‘(1) IN GENERAL.—Except as provided in para-
24
graph (3), a person who is registered to perform re-
25
08:15 Dec 15, 2021
H6184
15 
•HR 6184 IH
search on a controlled substance may perform manu-
1
facturing activities with small quantities of that sub-
2
stance, including activities described in paragraph 
3
(2), without being required to obtain a manufac-
4
turing registration, if— 
5
‘‘(A) the activities are performed for the 
6
purpose of the research; and 
7
‘‘(B) the activities and the quantities of 
8
the substance involved in the activities are stat-
9
ed in— 
10
‘‘(i) a notification submitted to the 
11
Attorney General under section 303(l); 
12
‘‘(ii) a research protocol filed with an 
13
application for registration approval under 
14
section 303(f); or 
15
‘‘(iii) a notification to the Attorney 
16
General that includes— 
17
‘‘(I) the name of the registrant; 
18
and 
19
‘‘(II) an attestation that the re-
20
search to be conducted with the small 
21
quantities of manufactured substance 
22
is consistent with the scope of the re-
23
search that is the basis for the reg-
24
istration. 
25
08:15 Dec 15, 2021
H6184
16 
•HR 6184 IH
‘‘(2) ACTIVITIES
INCLUDED.—Activities per-
1
mitted under paragraph (1) include— 
2
‘‘(A) processing the substance to create ex-
3
tracts, tinctures, oils, solutions, derivatives, or 
4
other forms of the substance consistent with— 
5
‘‘(i) the information provided as part 
6
of a notification submitted to the Attorney 
7
General under section 303(l); or 
8
‘‘(ii) a research protocol filed with an 
9
application for registration approval under 
10
section 303(f); and 
11
‘‘(B) dosage form development studies per-
12
formed for the purpose of requesting an inves-
13
tigational new drug exemption under section 
14
505(i) of the Federal Food, Drug, and Cos-
15
metic Act (21 U.S.C. 355(i)). 
16
‘‘(3) EXCEPTION
REGARDING
MARIHUANA.— 
17
The authority under paragraph (1) to manufacture 
18
substances does not include the authority to grow 
19
marihuana.’’. 
20
(g) TRANSPARENCY REGARDING SPECIAL PROCE-
21
DURES.—Section 303 of the Controlled Substances Act 
22
(21 U.S.C. 823), as amended by subsection (a), is amend-
23
ed by adding at the end the following: 
24
08:15 Dec 15, 2021
H6184
17 
•HR 6184 IH
‘‘(m) TRANSPARENCY REGARDING SPECIAL PROCE-
1
DURES.— 
2
‘‘(1) IN GENERAL.—If the Attorney General de-
3
termines, with respect to a controlled substance, that 
4
an application by a practitioner to conduct research 
5
with the substance should be considered under a 
6
process, or subject to criteria, different from the 
7
process or criteria applicable to applications to con-
8
duct research with other controlled substances in the 
9
same schedule, the Attorney General shall make 
10
public, including by posting on the website of the 
11
Drug Enforcement Administration— 
12
‘‘(A) the identities of all substances for 
13
which such determinations have been made; 
14
‘‘(B) the process and criteria that shall be 
15
applied to applications to conduct research with 
16
those substances; and 
17
‘‘(C) how the process and criteria described 
18
in subparagraph (B) differ from the process 
19
and criteria applicable to applications to con-
20
duct research with other controlled substances 
21
in the same schedule. 
22
‘‘(2) TIMING OF POSTING.—The Attorney Gen-
23
eral shall make information described in paragraph 
24
(1) public upon making a determination described in 
25
08:15 Dec 15, 2021
H6184
18 
•HR 6184 IH
that paragraph, regardless of whether a practitioner 
1
has submitted such an application at that time.’’. 
2
SEC. 4. RULEMAKING. 
3
(a) INTERIM FINAL RULES.—The Attorney Gen-
4
eral— 
5
(1) shall, not later than 1 year of the date of 
6
enactment of this Act, issue rules to implement this 
7
Act and the amendments made by this Act; and 
8
(2) may issue the rules under paragraph (1) as 
9
interim final rules. 
10
(b) PROCEDURE FOR FINAL RULE.— 
11
(1) 
EFFECTIVENESS
OF
INTERIM
FINAL 
12
RULES.—A rule issued by the Attorney General as 
13
an interim final rule under subsection (a) shall be-
14
come immediately effective as an interim final rule 
15
without requiring the Attorney General to dem-
16
onstrate good cause therefor, notwithstanding sub-
17
paragraph (B) of section 553(b) of title 5, United 
18
States Code. 
19
(2) OPPORTUNITY FOR COMMENT AND HEAR-
20
ING.—An interim final rule issued under subsection 
21
(a) shall give interested persons the opportunity to 
22
comment and to request a hearing. 
23
(3) FINAL RULE.—After the conclusion of such 
24
proceedings, the Attorney General shall issue a final 
25
08:15 Dec 15, 2021
H6184
19 
•HR 6184 IH
rule to implement this Act and the amendments 
1
made by this Act in accordance with section 553 of 
2
title 5, United States Code. 
3
Æ 
08:15 Dec 15, 2021
H6184
